Hidradenitis suppurativa (HS) is a chronic skin condition that typically affects hair follicles and sweat glands in the armpits, groin, buttocks, and breasts. This condition causes painful lumps to form under the skin and usually starts after puberty. Those who smoke or are overweight are more likely to develop HS. However, the exact cause is unknown. Medical and surgical therapy may reduce the symptoms and keep them under control.
To learn more about the causes and treatments for HS, Olympian Clinical Research (OCR) is hosting a research study on the condition. If you suffer from hidradenitis suppurativa and are considering participating in an HS research study with OCR, this guide will give you an idea of what to expect.
Purpose of the Study
This clinical research study aims to evaluate the safety and effectiveness of an investigational medication in treating HS. Hidradenitis suppurativa is a complex condition with limited treatment options. Therefore, clinical research studies provide an excellent opportunity to explore potential new treatments that may improve hidradenitis suppurativa symptoms, reduce the number of flare-ups, and enhance the quality of life for patients with HS.
Clinical trials for HS must comply with strict rules set by regulatory authorities to protect the rights and safety of participants. These rules include informed consent procedures, ethical considerations, and monitoring of adverse events. By adhering to these guidelines, clinical research studies can provide valuable information on the safety and efficacy of new treatments for hidradenitis suppurativa and ultimately help improve the lives of those living with this challenging condition.
Cost of Participation
If you qualify, participation in this research study is free of charge and provides a unique opportunity for patients to receive innovative treatments for HS without incurring any costs. Additionally, participants may receive compensation for their time and travel expenses to attend study visits. This compensation can be an added incentive to help cover expenses and offset any inconvenience associated with participating in the study. Overall, joining a hidradenitis suppurativa research study can be a rewarding experience both in terms of the potential benefits of the treatment and the financial support provided for your participation.
This research study will last about 13 months. You should expect to meet with your study doctor monthly to evaluate your progress and discuss your experience, symptoms, and overall health. Participating in a clinical research trial is optional, and you are free to withdraw at any time for any reason. Withdrawing from a study will not affect your future care, and you will be free to seek other treatments or consult with your doctor.
What to Expect During a Study Visit
During each study visit, you can expect to receive personalized attention and care from your study team. The visit will typically begin with questions about your overall health, followed by a physical examination of your skin. Depending on the visit, you may also be asked to complete questionnaires about your symptoms and their impact on your daily life. In addition, throughout the study, you may be asked to give regular blood samples for safety tests.
The study team will give you a thorough overview of what you can anticipate during each visit before deciding to participate in the study. This information is designed to help you make an informed decision about your participation and ensure you are comfortable with the study procedures.
The study is divided into two treatment periods. In the initial three-month treatment period, there’s a 67% possibility you will receive the active investigational medication, while there’s a 33% chance of receiving a placebo. During this period, neither you nor your doctor will know which medication you are receiving. This technique helps ensure unbiased results and allows researchers to accurately assess the investigational medication’s effects. After the initial treatment period, all participants will switch to taking the active investigational medication for an extra ten months while the study doctor continues monitoring their progress. Throughout the study, your study team will be available to answer any questions you may have. They will work with you to ensure your participation is as comfortable and convenient as possible.
Join a Hidradenitis Suppurativa Study at OCR
If you live with hidradenitis suppurativa and are interested in exploring new treatment options, you may be eligible to participate in an HS research study with Olympian Clinical Research. Joining our HS research study will grant you access to innovative treatments that may not be available through other channels.
You will receive personalized care from our experienced study team, including regular check-ups, skin examinations, and safety tests. Plus, you may be eligible for financial compensation for your participation. To see if you qualify for our hidradenitis suppurativa research study, please contact us today to see if you qualify by calling (813) 849-5566.